Survival Outcomes of Salvage Metastasectomy After Failure of Modern-Era Systemic Therapy for Melanoma
Authors:
- 4 August 2021
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 28 (11) , 6109-6123
Abstract
Metastasectomy for selected patients with melanoma was associated with improved survival in the era before effective systemic therapy. Emerging evidence shKeywords
This publication has 33 references indexed in Scilit:
- Post-operative survival following metastasectomy for patients receiving BRAF inhibitor therapy is associated with duration of pre-operative treatment and elective indicationJournal of Surgical Oncology, 2015
- Immunological Insights from Patients Undergoing Surgery on Ipilimumab for Metastatic MelanomaAnnals of Surgical Oncology, 2013
- Metastasectomy for Distant Metastatic Melanoma: Analysis of Data from the First Multicenter Selective Lymphadenectomy Trial (MSLT-I)Annals of Surgical Oncology, 2012
- Prognostic factors for survival in melanoma patients with brain metastasesCancer, 2010
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Complete metastasectomy in patients with stage IV metastatic melanomaThe Lancet Oncology, 2006
- Treatment of Oligometastases After Successful ImmunotherapySeminars in Radiation Oncology, 2006
- Classification of Surgical ComplicationsAnnals of Surgery, 2004
- High-Dose Recombinant Interleukin 2 Therapy for Patients With Metastatic Melanoma: Analysis of 270 Patients Treated Between 1985 and 1993Journal of Clinical Oncology, 1999
- Resection and adjuvant immunotherapy for melanoma metastatic to the lung and thoraxThe Journal of Thoracic and Cardiovascular Surgery, 1995